These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29017158)

  • 1. Beneficial Effects of n-3 Fatty Acids on Cardiometabolic and Inflammatory Markers in Type 2 Diabetes Mellitus: A Clinical Trial.
    Mazaherioun M; Djalali M; Koohdani F; Javanbakht MH; Zarei M; Beigy M; Ansari S; Rezvan N; Saedisomeolia A
    Med Princ Pract; 2017; 26(6):535-541. PubMed ID: 29017158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of n-3 Polyunsaturated Fatty Acid Supplementation on Metabolic and Inflammatory Biomarkers in Type 2 Diabetes Mellitus Patients.
    Jacobo-Cejudo MG; Valdés-Ramos R; Guadarrama-López AL; Pardo-Morales RV; Martínez-Carrillo BE; Harbige LS
    Nutrients; 2017 Jun; 9(6):. PubMed ID: 28587203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with high-dose n-3 PUFAs has no effect on platelet function, coagulation, metabolic status or inflammation in patients with atherosclerosis and type 2 diabetes.
    Poreba M; Mostowik M; Siniarski A; Golebiowska-Wiatrak R; Malinowski KP; Haberka M; Konduracka E; Nessler J; Undas A; Gajos G
    Cardiovasc Diabetol; 2017 Apr; 16(1):50. PubMed ID: 28410617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel adiponectin-resistin (AR) and insulin resistance (IRAR) indexes are useful integrated diagnostic biomarkers for insulin resistance, type 2 diabetes and metabolic syndrome: a case control study.
    Lau CH; Muniandy S
    Cardiovasc Diabetol; 2011 Jan; 10():8. PubMed ID: 21251282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of n-3 polyunsaturated fatty acids on adiponectin levels and AdipoR gene expression in patients with type 2 diabetes mellitus: a randomized, placebo-controlled, double-blind clinical trial.
    Mazaherioun M; Saedisomeolia A; Javanbakht MH; Koohdani F; Eshraghian MR; Djalali M
    Arch Med Sci; 2017 Jun; 13(4):716-724. PubMed ID: 28721137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of NRF2 gene expression and antioxidant status in patients with type 2 diabetes mellitus after supplementation with omega-3 polyunsaturated fatty acids: A double-blind randomised placebo-controlled clinical trial.
    Golpour P; Nourbakhsh M; Mazaherioun M; Janani L; Nourbakhsh M; Yaghmaei P
    Diabetes Res Clin Pract; 2020 Apr; 162():108120. PubMed ID: 32194222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal serum leptin, adiponectin, resistin and monocyte chemoattractant protein-1 levels in different types of diabetes mellitus.
    Kapustin RV; Chepanov SV; Babakov VN; Rogovskaya NY; Kopteeva EV; Alekseenkova EN; Arzhanova ON
    Eur J Obstet Gynecol Reprod Biol; 2020 Nov; 254():284-291. PubMed ID: 33039836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omega-3 polyunsaturated fatty acids favourably modulate cardiometabolic biomarkers in type 2 diabetes: a meta-analysis and meta-regression of randomized controlled trials.
    O'Mahoney LL; Matu J; Price OJ; Birch KM; Ajjan RA; Farrar D; Tapp R; West DJ; Deighton K; Campbell MD
    Cardiovasc Diabetol; 2018 Jul; 17(1):98. PubMed ID: 29981570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of n-3 PUFAs on circulating adiponectin and leptin in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.
    Farimani AR; Hariri M; Azimi-Nezhad M; Borji A; Zarei S; Hooshmand E
    Acta Diabetol; 2018 Jul; 55(7):641-652. PubMed ID: 29453672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in lipoprotein particle subclasses, standard lipids, and apolipoproteins after supplementation with n-3 or n-6 PUFAs in abdominal obesity: A randomized double-blind crossover study.
    Grytten E; Laupsa-Borge J; Bohov P; Bjørndal B; Strand E; Skorve J; Nordrehaug JE; Berge RK; Rostrup E; Mellgren G; Dankel SN; Nygård OK
    Clin Nutr; 2021 May; 40(5):2556-2575. PubMed ID: 33933722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liraglutide treatment causes upregulation of adiponectin and downregulation of resistin in Chinese type 2 diabetes.
    Li D; Xu X; Zhang Y; Zhu J; Ye L; Lee KO; Ma J
    Diabetes Res Clin Pract; 2015 Nov; 110(2):224-8. PubMed ID: 26376464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes.
    Shetty GK; Economides PA; Horton ES; Mantzoros CS; Veves A
    Diabetes Care; 2004 Oct; 27(10):2450-7. PubMed ID: 15451915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omega-3 PUFAs improved endothelial function and arterial stiffness with a parallel antiinflammatory effect in adults with metabolic syndrome.
    Tousoulis D; Plastiras A; Siasos G; Oikonomou E; Verveniotis A; Kokkou E; Maniatis K; Gouliopoulos N; Miliou A; Paraskevopoulos T; Stefanadis C
    Atherosclerosis; 2014 Jan; 232(1):10-6. PubMed ID: 24401211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment for 2 mo with n 3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study.
    Kabir M; Skurnik G; Naour N; Pechtner V; Meugnier E; Rome S; Quignard-Boulangé A; Vidal H; Slama G; Clément K; Guerre-Millo M; Rizkalla SW
    Am J Clin Nutr; 2007 Dec; 86(6):1670-9. PubMed ID: 18065585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a 6-month multi-strain probiotics supplementation in endotoxemic, inflammatory and cardiometabolic status of T2DM patients: A randomized, double-blind, placebo-controlled trial.
    Sabico S; Al-Mashharawi A; Al-Daghri NM; Wani K; Amer OE; Hussain DS; Ahmed Ansari MG; Masoud MS; Alokail MS; McTernan PG
    Clin Nutr; 2019 Aug; 38(4):1561-1569. PubMed ID: 30170781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome.
    Mohammadi E; Rafraf M; Farzadi L; Asghari-Jafarabadi M; Sabour S
    Asia Pac J Clin Nutr; 2012; 21(4):511-8. PubMed ID: 23017309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipokines, inflammatory mediators, and insulin-resistance parameters may not be good markers of metabolic syndrome after liver transplant.
    Anastácio LR; de Oliveira MC; Diniz KG; Ferreira AM; Lima AS; Correia MI; Vilela EG
    Nutrition; 2016 Sep; 32(9):921-7. PubMed ID: 27189907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships among resistin, adiponectin, and leptin and microvascular complications in patients with type 2 diabetes mellitus.
    Wang LK; Wang H; Wu XL; Shi L; Yang RM; Wang YC
    J Int Med Res; 2020 Apr; 48(4):300060519870407. PubMed ID: 31891278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-3 polyunsaturated fatty acids improve lipoprotein particle size and concentration in Japanese patients with type 2 diabetes and hypertriglyceridemia: a pilot study.
    Ide K; Koshizaka M; Tokuyama H; Tokuyama T; Ishikawa T; Maezawa Y; Takemoto M; Yokote K
    Lipids Health Dis; 2018 Mar; 17(1):51. PubMed ID: 29544483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omega-3 polyunsaturated fatty acids increase plasma adiponectin to leptin ratio in stable coronary artery disease.
    Mostowik M; Gajos G; Zalewski J; Nessler J; Undas A
    Cardiovasc Drugs Ther; 2013 Aug; 27(4):289-95. PubMed ID: 23584593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.